Among DCIS, 22 of 60 (36.7%) showed cytoplasmic TG2, while majority of the cases (50/60; 83.3%) showed no detectable TG2 expression in stroma (Figure 2(ii), a and b, Table 1). This evidence concerns the gene TGM2 and ductal breast carcinoma in situ.